Quantcast

Latest Ketones Stories

FDA Urges Doctors To Stop Prescribing Combination Drugs Containing More Than 325mg Acetaminophen
2014-01-15 10:28:49

Brett Smith for redOrbit.com - Your Universe Online Citing the potential risk for liver damage, the Food and Drug Administration (FDA) has asked doctors to stop prescribing combination medications containing over 325 milligrams of acetaminophen. The move comes after the federal regulator issued a similar request in 2011 to companies manufacturing these combination medications. "There are no available data to show that taking more than 325 milligrams of acetaminophen per dosage unit...

2014-01-13 12:26:59

Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel for Stine Seed Company, Added to KemPharm's Board CORALVILLE, Iowa, Jan. 13, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed...

2014-01-13 08:30:02

Suncoast Rehab Center comments on the growth of painkiller addiction--Suncoast attributes the rise in addiction to unscrupulous prescribing practices and a lack of public education. SPRING HILL, Fla., Jan. 13, 2014 /PRNewswire-iReach/ -- In recent years, medical practitioners have written millions of prescriptions for drugs such as Vicodin, Percocet and OxyContin, which contain compounds derived from opium--one of the world's most powerful painkillers--all in an effort to relieve...

2014-01-11 23:02:13

The New Year brings the opportunity for a fresh start for American youth struggling with drug and alcohol addiction. Narconon Fresh Start, a successful drug and alcohol rehabilitation program with eight centers across the United States has released details about their New Life Detoxification Method and its' success in treating young addicts throughout the country. Glendale, California (PRWEB) January 11, 2014 The New Year brings the opportunity for a fresh start for American youth...

2014-01-10 08:23:03

BEMA Buprenorphine Phase 3 opioid naive study database lock imminent; triggers $10M milestone payment from Endo Pharmaceuticals RALEIGH, N.C., Jan. 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced updates to the company's anticipated 2014 milestones for its product portfolio, including the imminent database lock for the Phase 3 clinical study of BEMA Buprenorphine for the treatment of moderate to severe chronic pain in opioid naive subjects, with...

2014-01-09 12:26:30

CORALVILLE, Iowa, Jan. 9, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D. will present at the Biotech Showcase(TM) 2014 Conference being held in San Francisco January 13-15, 2014. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline, including KP201, the...

2014-01-08 12:30:25

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO and PARSIPPANY, N.J., Jan. 8, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the New Drug Application (NDA) for its investigational, oral, once-daily direct factor Xa-inhibitor SAVAYSA(TM) (edoxaban) Tablets has been submitted to the U.S. Food...

2014-01-07 12:28:27

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO and MUNICH, Jan. 7, 2014 /PRNewswire/ -- Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application (MAA) for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency...

2013-12-23 23:00:43

A Madison treatment center is adding programs toward helping people suffering from drug and alcohol dependency. Call (608) 318-4393 for an appointment at Drug Addiction Treatment Centers. Madison, WI (PRWEB) December 23, 2013 A Madison treatment center is launching a program in support of individuals that are seeking help for their substance abuse problems through Drug Addiction Treatment Centers. According to a report from the U.S. Department of Health and Human Services, in 2012, 4.0...

2013-12-19 11:47:26

Patients with atrial fibrillation – an irregular and often abnormally fast heartbeat – have nearly double the risk of suffering a stroke in the first 30 days after starting to take the anti-clotting drug warfarin compared to non-users, according to a study of over 70,000 patients. The study, published online today (Thursday) in the European Heart Journal, found that the risk was particularly high in the first week after patients started to take the drug. In contrast, once the first 30...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related